Delcath Systems, Inc. (NASDAQ: DCTH) is a Healthcare company (Medical - Devices) with a market capitalization of $674M. The Maz Rating grades it against the other companies in its sector.
Delcath Systems, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $19.37, Delcath Systems, Inc. trades at 109.0x trailing earnings, 6.1x sales and 5.2x book value, with an EV/EBITDA of 66.9. Over the last twelve months it generated about $110M of revenue and $6M of net income. It runs a gross margin of 87.6%, an operating margin of 5.2% and a net margin of 6.1%. It shows return on equity of 5.6%, return on invested capital of 3.1% and a free cash flow yield of 3.0%. On the balance sheet: a debt-to-equity ratio of 0.02 and a current ratio of 10.87. Over the past 52 weeks the share price ranged from $8.12 to $22.51, with a beta of 0.60.
Delcath Systems, Inc. does not currently pay a dividend.
11 Wall Street analyst ratings cover the stock: 8 Buy, 2 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.